BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 12404199)

  • 1. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
    Vigna GB; Donegà P; Zanca R; Barban A; Passaro A; Pansini F; Bonaccorsi G; Mollica G; Fellin R
    Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent use of simvastatin and estrogen--progestin therapy compared with each therapy alone for hypercholesterolemia in postmenopausal women.
    Darling GM; Johns JA; McCloud PI; Davis SR
    Climacteric; 1999 Sep; 2(3):181-8. PubMed ID: 11910595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Christodoulakos GE; Lambrinoudaki IV; Panoulis CP; Papadias CA; Kouskouni EE; Creatsas GC
    Gynecol Endocrinol; 2004 May; 18(5):244-57. PubMed ID: 15346660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
    Sbarouni E; Kyriakides ZS; Kremastinos DTh
    J Am Coll Cardiol; 1998 Nov; 32(5):1244-50. PubMed ID: 9809932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
    Sendag F; Karadadas N; Ozsener S; Bilgin O
    Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on lipid levels in hypercholesterolemic women].
    Dobrzycka B; Dobrzycki S; Lenczewski A; Terlikowski S; Kulikowski M
    Ginekol Pol; 2003 Sep; 74(9):937-42. PubMed ID: 14674148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.
    Park JS; Jung HH; Yang WS; Kim SB; Min WK; Chi HS
    Nephrol Dial Transplant; 2000 Nov; 15(11):1835-40. PubMed ID: 11071974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
    Dobs AS; Schrott H; Davidson MH; Bays H; Stein EA; Kush D; Wu M; Mitchel Y; Illingworth RD
    Metabolism; 2000 Sep; 49(9):1234-8. PubMed ID: 11016911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
    Schlegel W; Petersdorf LI; Junker R; Schulte H; Ebert C; Von Eckardstein A
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):643-51. PubMed ID: 10594527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combination therapy with estrogen plus simvastatin on lipoprotein metabolism in postmenopausal women with type IIa hypercholesterolemia.
    Wakatsuki A; Okatani Y; Ikenoue N
    Atherosclerosis; 2000 May; 150(1):103-11. PubMed ID: 10781640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women.
    Rabbani LE; Seminario NA; Sciacca RR; Chen HJ; Giardina EG
    J Am Coll Cardiol; 2002 Dec; 40(11):1991-9. PubMed ID: 12475460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.